Connect
Description
Researcher Keith Knutson, Ph.D., and oncologist Saranya Chumsri, M.D., discuss current breast cancer research and treatment options.
Learn more about:
- Dr. Knutson's vaccine study
- the future of breast cancer research
- breast cancer care
Researcher Keith Knutson, Ph.D., and oncologist Saranya Chumsri, M.D., discuss current breast cancer research and treatment options.
Learn more about:
ConnectConnect with thousands of patients and caregivers for support and answers.
Like
Helpful
Hug
It appears that after treatment of ER/PR + breast cancer treatment, the standard treatment for post-menopausal women is hormone suppression for 5-10 years and hope it does not recurred. This results in many side effects and anxiety.
Is there any new research being done to prevent or predict ER/PR + breast cancer recurrence?
Thanks
Laurie
-
Like -
Helpful -
Hug
2 ReactionsWe're going to start in a few minutes. Dr. Chumsri was delayed with a patient.
I'm new to this. Can I listen live from my facebook page or do I go somewhere else?
My daughter has a PTEN mutation which places her more at risk for breast cancer. Is there anything she can/should be doing to help prevent breast cancer from occurring?
Hello! I am joining late. Has TNBC vaccine study opened back up yet? Thank you! I appreciate all you do for your patients here at Mayo in JAX.
To add to the previous question - the TNBC immunotherapy (not sure if this is the right word). study.
You can find clinical trials at Mayo Clinic here: https://www.mayo.edu/research/clinical-trials.
Yes. But I am asking about the vaccine study that recently closed - however, according to Dr. Chumsri - it could possibly reopen.
I am a breast cancer survivor - diagnosed at age 52 - ER/PR positive. I have 2 adult daughters. What testing/care would you recommend to monitor them for breast cancer?
I was in a study for hormone suppression prior to surgery that measured Ki67. What is Ki67 and is it just a measurement in breast cancer or also in other cancer?